Djibouti vs Pakistan: Share of the population living with HIV receiving antiretroviral therapy
Djibouti
24.7%
in 2024
Pakistan
16.1%
in 2024
Djibouti rank
145th
Pakistan rank
148th
Share of the population living with HIV receiving antiretroviral therapy over time
- Djibouti
- Pakistan
How they compare
Djibouti currently reports 24.7% against 16.1% in Pakistan, a difference of 8.6%.
That makes Djibouti's figure about 1.5 times Pakistan's.
The two have swapped places 1 time across 33 shared years of data; in 1991 it was Pakistan ahead.
Djibouti ranks 145th and Pakistan ranks 148th of 149 countries.
Djibouti has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Djibouti | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 2.2% | 1.2% | 1.0% | Djibouti |
| 2010s | 14.4% | 4.9% | 9.4% | Djibouti |
| 2020s | 22.6% | 12.6% | 10.1% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Djibouti or Pakistan?
- Djibouti, at 24.7% against 16.1% in Pakistan as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Djibouti and Pakistan?
- 8.6%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Pakistan?
- 33 years are reported by both, from 1991 to 2024.
- How do Djibouti and Pakistan rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Djibouti ranks 145th and Pakistan ranks 148th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.